Hoang Mai Le, Giuseppe Querques, Sacha Guenoun, Djazia El Ghazi, Walid M Haddad, Alexandra Mouallem, Oudy Semoun, Eric H Souied
{"title":"Acute intra ocular inflammation following intravitreal injections of faricimab: A multicentric case series.","authors":"Hoang Mai Le, Giuseppe Querques, Sacha Guenoun, Djazia El Ghazi, Walid M Haddad, Alexandra Mouallem, Oudy Semoun, Eric H Souied","doi":"10.1177/11206721241306225","DOIUrl":"10.1177/11206721241306225","url":null,"abstract":"<p><p>PurposeTo report 8 cases of acute intra ocular inflammation (IOI) following intravitreal injections (IVI) of faricimab in patients with age related macular degeneration (AMD), retinal vein occlusion (RVO) and macular neovascularization associated with chronic central serous retinopathy (CSR).MethodsThis is a multicentric retrospective observational case-series. Cases of acute IOI that occurred in 5 different institutions in France and Italy between November 2023 and June 2024 were reported.Results8 eyes of 8 patients presented with acute IOI following IVI of faricimab. Best corrected visual acuity (BCVA) at the time of the IOI event varied between counting fingers and 20/25. 6 patients had neovascular AMD, 1 patient had a macular edema secondary to central RVO and 1 patient had a macular neovascularization associated with chronic CSR. Mean delay between the last IVI of faricimab and the assessment of the IOI event was 10.0 days. Presentation of IOI varied among patients. 6 patients presented with vitritis with varying severity. One of them had an associated papillitis. One patient presented with an anterior uveitis without vitritis. Corticosteroids were used in 5 cases. 2 cases resolved spontaneously. Surgery was needed in 1 case. These 8 cases of IOI occurred out of a total of 1923 IVI of faricimab performed with an estimated frequency of 0.41%.ConclusionAcute IOI may happen after IVI of faricimab. Severity of inflammation varies and treatment should be adjusted according to the clinical presentation.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1358-1365"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142846105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intraoperative OCT evaluation of the stability and centering of carlevale IOL with different intrascleral fixation techniques.","authors":"Gregorio Lo Giudice, Claudio Brancato, Maura Mancini, Antonino Pioppo, Aurelio Imburgia","doi":"10.1177/11206721241306777","DOIUrl":"10.1177/11206721241306777","url":null,"abstract":"<p><p>BackgroundTo evaluate intrascleral plug stability and correct centring of the IOL in three different surgical techniques using intraoperative anterior segment OCT.MethodsThis retrospective scientific study was conducted by reviewing patient records from the Ophthalmology Unit at the Civico Hospital of Palermo, covering the period between 2021 and 2022. Three distinct groups of patients, each consisting of 7 eyes from 7 individual patients, were included in this study. The first group received a quadrangular scleral flap (3.5 × 3.5 mm) that covered intrascleral plugs. The second group had two intrascleral pockets created with the insertion of plugs inside these pockets. The third group had one intrascleral pocket created to cover the intrascleral plugs. Intraoperative anterior segment (AS)-OCT was used to monitor the positioning of the plugs and the tilt of the IOL. The analyzed parameters are: best-corrected visual acuity (BCVA), subjective refraction, intraocular pressure (IOP), pachymetry, macular thickness, endothelial cell loss, intraoperative and postoperative complications, IOL tilting, and optic plate decentration.ResultsThe examined parameters showed uniformity among the groups. Postoperative best-corrected visual acuity (BCVA), subjective refraction, intraocular pressure (IOP), pachymetry, and macular thickness exhibited no significant differences between the three groups. Endothelial cell loss ranged between 10.4% and 13.1% across the patient groups. No intraoperative or postoperative complications were reported. No IOL tilting or optic plate decentration was reported. The duration of surgeries was similar among the groups.ConclusionsThe three different scleral fixation techniques have been shown to be equally effective, demonstrating the usefulness of intraoperative AS-OCT for the stability and centring of Carlevale IOLs.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1179-1186"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bruna Cunha, Pedro Gil, Catarina Barão, Diogo Hipólito-Fernandes, Vítor Maduro, João Feijão, Nuno Alves
{"title":"Anterior chamber morphological and refractive outcomes following phacoemulsification in pseudoexfoliative eyes: A case-control study.","authors":"Bruna Cunha, Pedro Gil, Catarina Barão, Diogo Hipólito-Fernandes, Vítor Maduro, João Feijão, Nuno Alves","doi":"10.1177/11206721241310345","DOIUrl":"10.1177/11206721241310345","url":null,"abstract":"<p><p>PurposeTo compare changes in angle morphology, anterior chamber depth (ACD) and refractive prediction error (PE) after phacoemulsification between pseudoexfoliative (PEX) and non-PEX eyes.MethodsProspective case-control study of eyes submitted to cataract surgery. Biometric data and angle parameters - Anterior Chamber Angle (ACA), Angle Opening Distance (AOD), Scleral Spur Angles (SSA) and Trabecular Iris Space Area (TISA) - were measured preoperatively and 1-month postoperatively through swept-source anterior segment optical coherence tomography. Postoperative refractive prediction error (PE) was calculated using an optimized A-constant and the Kane formula.ResultsSixty eyes (30 PEX and 30 non-PEX) of 60 patients were included. Preoperative angle analysis revealed a lower ACA, AOD, SSA and TISA in PEX group (<i>p</i> < 0.05), without biometric differences (<i>p</i> > 0.05). A tendency for a higher magnitude of morphometric angle changes in PEX eyes was observed, with a superior increase of SSA at 500 µm (0°) and TISA at 750 µm (0°) (<i>p</i> = 0.030 and <i>p</i> = 0.041, respectively). The anterior chamber deepened in both groups (<i>p</i> = 0.01), with arithmetic and percentile change being higher in PEX group (<i>p</i> = 0.017 and <i>p</i> = 0.047, respectively). A significant PE hyperopic shift was observed (<i>p</i> = 0.035) only in PEX group.ConclusionsPseudoexfoliative eyes with cataract have narrower angles, revealing a tendency for higher angle opening after surgery, along with an increased ACD deepening compared to non-PEX eyes, which may be explained by PEX-associated zonular laxity. Moreover, a significant hyperopic shift was observed in PEX eyes, a relevant fact to take into consideration when selecting intraocular lens power.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1213-1220"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143022529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nan Guo, Zhenlin Fan, Yitong Chen, Qian Li, Limin Guo
{"title":"Endocrine mucin-producing sweat gland carcinoma: Case report and literature review.","authors":"Nan Guo, Zhenlin Fan, Yitong Chen, Qian Li, Limin Guo","doi":"10.1177/11206721251327644","DOIUrl":"10.1177/11206721251327644","url":null,"abstract":"<p><p>PurposeTo provide more basis for further diagnosis and differentiation for Endocrine Mucin-Producing Sweat Gland Carcinoma (EMPSGC), we offer a case report and a comprehensive review of the epidemiology, immunohistochemical findings, and molecular mechanisms underlying EMPSGC.Case descriptionWe herein present a case of a 70-year-old Chinese male patient who presented with a painless, progressively enlarging skin mass at his right lateral canthus. Histopathological examination revealed solid papillary growth patterns with intracellular mucin, and immunohistochemical staining was positive for Ki-67, P53, EMA, CK7, GATA3, CgA, Syn, INSM1, and AR, confirming the diagnosis of EMPSGC. Literature revealed that EMPSGC is a rare, low-grade malignant tumor with neuroendocrine differentiation. Key immunohistochemical markers include CK7, GATA-3, and INSM1, which aid in diagnosis. Hormone receptors such as ER, PgR, and AR are frequently expressed. The recurrence risk ranges from 7.11% to 14.3%, with rare cases of metastasis to the parotid gland, lungs, and skeletal system. Following surgical resection and subsequent pathological examination, the lesion was diagnosed as EMPSGC. In this report, we delineate the clinical presentation, Hematoxylin and eosin (H&E) staining features, and immunohistochemical characteristics of this case. We also conduct a literature review to enhance the understanding of EMPSGC.ConclusionEMPSGC is a relatively rare type of eyelid tumor in ophthalmic diagnosis and treatment. However, it poses a significant risk of misdiagnosis with other ocular tumors. Any eyelid mass demands attention, and necessitates prompt resection followed by intraoperative and/or postoperative pathological examination to avoid misdiagnose and poor prognosis.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"NP49-NP53"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143742692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mariacristina Parravano, Francesco Viola, Massimo Nicolò, Stela Vujosevic, Laura Bianchino, Emilia Sicari, Giulia Villa, Paolo Lanzetta
{"title":"Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study.","authors":"Mariacristina Parravano, Francesco Viola, Massimo Nicolò, Stela Vujosevic, Laura Bianchino, Emilia Sicari, Giulia Villa, Paolo Lanzetta","doi":"10.1177/11206721241310628","DOIUrl":"10.1177/11206721241310628","url":null,"abstract":"<p><p>PurposeAge-related macular degeneration (AMD) is a leading cause of irreversible vision loss, particularly neovascular AMD (nAMD). This study aimed to investigate the real-world treatment patterns, effectiveness, and safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapies for anti-VEGF naïve nAMD patients in Italy.MethodsRADIANCE is a retrospective, observational, multicenter cohort study conducted at 13 clinical sites across Italy. The study enrolled all consecutive patients with nAMD, naïve to any intraocular anti-VEGF treatment and who initiated therapy with aflibercept, ranibizumab, or bevacizumab between January 2017 and November 2018. The primary objective of this study was to evaluate changes in visual acuity (VA) 52 weeks after initiating treatment with anti-VEGF.ResultsA total of 405 patients were enrolled; of these, 263 patients had at least two VA measurements and were included in the completer analysis (CA) set. At 52 weeks, the median VA change from baseline in the CA set was +1 letter, with 41.1% showing ≥ 5-letter improvement. Stratified by anti-VEGF agent, no statistically significant differences were observed. Overall, patients received a median of 5.0 (25th-75th percentile 3-6) injections of the initial anti-VEGF agent during the first year. Patients receiving ≥ 6 injections in the first year showed better VA outcomes. Undertreatment was evident at decreasing injection frequency over time.ConclusionThe results of the RADIANCE study suggest an overall moderate effectiveness after 1 year of treatment with anti-VEGF in naïve patients with nAMD in Italy. Real-world outcomes demonstrated suboptimal treatment with no significant differences among anti-VEGF agents.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1366-1375"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143122415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana Rita Viana, Matteo Ripa, André Silva, Veronika Matello, Barbara Parolini
{"title":"Preliminary efficacy and safety results of a new macular buckle model (NPB<sup>®</sup>) in myopic traction maculopathy.","authors":"Ana Rita Viana, Matteo Ripa, André Silva, Veronika Matello, Barbara Parolini","doi":"10.1177/11206721241310471","DOIUrl":"10.1177/11206721241310471","url":null,"abstract":"<p><p>PurposeTo describe the efficacy and safety outcomes of NPB<sup>®</sup> macular buckle (MB) in myopic traction maculopathy (MTM).MethodsA monocentric, prospective cohort study of the naïve eyes who underwent MB surgery, alone or combined with <i>pars plana</i> vitrectomy (PPV) for MTM, using the new NPB<sup>®</sup> buckle, between December 2022 and June 2024. The anatomical results, postoperative complications, and MB ease of use were analyzed as the main outcomes. Secondary outcomes included changes in best-corrected visual acuity (BCVA), axial length (AL), and intraocular pressure (IOP).ResultsForty eyes of 39 patients were included, 34 (85%) were female. MB implantation alone was performed in 32 eyes (80%) and combined surgery in 8 (20%). At the final visit, 22 eyes (56,4%) \"resolved\" and 17 (43,6%) \"improved\" their retinal status, and 26 eyes (66,7%) \"resolved\", 8 (20,5%) \"improved\" and 5 (12,8%) \"unchanged\" their foveal status. Thirteen (32,5%) had repositioning surgery mainly due to MB decentration. Early complications (month 1) included diplopia in 3 eyes (7,5%) and elevation deficit without diplopia in 2 (5,0%). Late complications (month 6) involved mild buckle exposure in 3 cases (7,5%). No cases required MB removal or additional PPV. BCVA improved from 0,61 ± 0,35 to 0,49 ± 0,38 logMAR (<i>p</i> = 0,013), AL changed from 31,5 ± 2,2 to 30,0 ± 2,2 mm (<i>p</i> < 0,001), and IOP changed from 16,0 ± 2,7 to 14,5 ± 3,3 mmHg (<i>p</i> = 0,013), between the baseline and the final visit.ConclusionsThe new MB model is an effective and safe technique for MTM treatment as a first-line strategy, alone or in combination with PPV.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1402-1412"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142921173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Victoria Marechal, Francesca Amoroso, Mathilde M Goudot, Rania Lakraa, Eric Souied
{"title":"Roth spots revealing pernicious anemia in a diabetic patient.","authors":"Victoria Marechal, Francesca Amoroso, Mathilde M Goudot, Rania Lakraa, Eric Souied","doi":"10.1177/11206721251323306","DOIUrl":"10.1177/11206721251323306","url":null,"abstract":"<p><p>PurposeTo report a case of pernicious anemia in a patient presenting with white-centered hemorrhages.MethodCase report.ResultsA 64-year-old man with uncontrolled hypertension, insulin-dependent type 2 diabetes, dyslipidemia, and diabetic retinopathy presented with significant bilateral visual acuity reduction. Ophthalmological examination revealed severe diabetic maculopathy, multiple peripapillary Roth spots and hemorrhages. Laboratory tests identified macrocytic anemia with severe vitamin B12 deficiency and an endoscopic biopsy of the gastric fundus led to the diagnosis of pernicious anemia. The patient received blood transfusion, vitamin B12 supplementation and underwent intravitreal anti-VEGF (aflibercept) injections and retinal panphotocoagulation. Over two months, the patient exhibited marked improvement in visual acuity and partial resolution of retinal abnormalities.ConclusionRoth spots are a nonspecific sign that can be found in various pathologies, sometimes severe, such as pernicious anemia. In those cases, adequate vitamin B12 supplementation can resolve the signs and symptoms. Therefore, it is vital to carry out a comprehensive systemic etiological work-up to quickly treat the underlying cause, keeping in mind that multiple pathologies may coexist.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"NP21-NP24"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of orbital rheumatoid nodule.","authors":"Irene Bermudez-Castellanos, Silvia Hernández García, Patricia Callejo Perez, Alicia Galindo-Ferreiro","doi":"10.1177/11206721251324240","DOIUrl":"10.1177/11206721251324240","url":null,"abstract":"<p><p>IntroductionRheumatoid nodules are one of the most common extra-articular manifestations in rheumatoid arthritis (RA) being extremely uncommon in the ocular and periocular area. To the authors' knowledge, this is the second case of an orbital rheumatoid nodule.Case descriptionA 44-year-old woman with RA presented with a painful hard mass in the inferolateral right orbital rim causing mild lower lid retraction, ptosis and exophthalmos. Magnetic Resonance Imaging showed a extraconal mass involving the lower eyelid and fat tissue of the infratemporal fossa. An incisional biopsy demonstrated an orbital rheumatoid nodule.ConclusionsRheumatoid nodule's should be considered as a differential diagnosis for an orbital tumour found in patients with RA.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"NP39-NP43"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tuan Nguyen, Joshua Ong, Venkata Jonnakuti, Mouayad Masalkhi, Ethan Waisberg, Sarah Aman, Nasif Zaman, Prithul Sarker, Zhen Ling Teo, Daniel S W Ting, Darren S J Ting, Alireza Tavakkoli, Andrew G Lee
{"title":"Artificial intelligence in the diagnosis and management of refractive errors.","authors":"Tuan Nguyen, Joshua Ong, Venkata Jonnakuti, Mouayad Masalkhi, Ethan Waisberg, Sarah Aman, Nasif Zaman, Prithul Sarker, Zhen Ling Teo, Daniel S W Ting, Darren S J Ting, Alireza Tavakkoli, Andrew G Lee","doi":"10.1177/11206721251318384","DOIUrl":"10.1177/11206721251318384","url":null,"abstract":"<p><p>Refractive error is among the leading causes of visual impairment globally. The diagnosis and management of refractive error has traditionally relied on comprehensive eye examinations by eye care professionals, but access to these specialized services has remained limited in many areas of the world. Given this, artificial intelligence (AI) has shown immense potential in transforming the diagnosis and management of refractive error. We review AI applications across various aspects of refractive error care - from axial length prediction using fundus images to risk stratification for myopia progression. AI algorithms can be trained to analyze clinical data to detect refractive error as well as predict associated risks of myopia progression. For treatments such as implantable collamer and orthokeratology lenses, AI models facilitate vault size prediction and optimal lens fitting with high accuracy. Furthermore, AI has demonstrated promise in optimizing surgical planning and outcomes for refractive procedures. Emerging digital technologies such as telehealth, smartphone applications, and virtual reality integrated with AI present novel avenues for refractive error screening. We discuss key challenges, including limited validation datasets, lack of data standardization, image quality issues, population heterogeneity, practical deployment, and ethical considerations regarding patient privacy that need to be addressed before widespread clinical implementation.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1456-1480"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143987987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rémi Yaïci, Lilly Khamsy, Jelena Potic, Sorcha Ní Dhubhghaill, Massira Sanogo, François Lefebvre, Wagih Aclimandos, Rimvydas Asoklis, Huban Atilla, Catherine Creuzot-Garcher, Denise Curtin, Barbara Cvenkel, Lisa Flanagan, Tero T Kivelä, Anna Maino, Rafael Martinez Costa, Helena Prior Filipe, Marcin Stopa, Brendan Strong, Marie José Tassignon, Renata Ivekovic, Siegfried Priglinger, Joerg Sturmer, Tristan Bourcier
{"title":"Cataract surgical training: Analysis of the results of the European Board of Ophthalmology survey in the Swiss cohort.","authors":"Rémi Yaïci, Lilly Khamsy, Jelena Potic, Sorcha Ní Dhubhghaill, Massira Sanogo, François Lefebvre, Wagih Aclimandos, Rimvydas Asoklis, Huban Atilla, Catherine Creuzot-Garcher, Denise Curtin, Barbara Cvenkel, Lisa Flanagan, Tero T Kivelä, Anna Maino, Rafael Martinez Costa, Helena Prior Filipe, Marcin Stopa, Brendan Strong, Marie José Tassignon, Renata Ivekovic, Siegfried Priglinger, Joerg Sturmer, Tristan Bourcier","doi":"10.1177/11206721241304052","DOIUrl":"10.1177/11206721241304052","url":null,"abstract":"<p><p>IntroductionThis study, part of a series, analyses the Swiss cohort from an EBO survey on cataract surgery training in Europe, focusing on Switzerland's unique program. The survey identifies two models: training all residents in surgery, and a \"high-volume surgeon\" model where only some learn CS post-residency.MethodsThis study analyses the survey results of Swiss participants in the EBO examinations (2018-2022) and compared them with the most important cohorts (Germany, France and Spain).ResultsOut of 251 respondents, 87 (34.7%) answered the questionnaire. Most (70.1%) had taken the EBO exam between 2021-2022, with the majority of study participants being men (55.2%) with a median age of 34 years and came from 12 different cantons. Two third (68.8%) of respondents had not performed any steps of cataract surgery on patients during their residency. Notably, 22.1% stated that they had carried out 10 or more training sessions on virtual reality simulator, 5.8% on synthetic eyes and 21% on animal eyes. A notable discrepancy was observed between participants with 10 or more training sessions and those without specific training in four key areas: self-assessed confidence and ability to perform cataract surgery (p = 0.006), management of challenging cases (p = 0.027), handling complications like posterior capsular tear (p = 0.031) and in performing corneal sutures (p = 0.023).DiscussionSwitzerland fits into the \"high-volume surgeon\" model group; extensive simulation-based training there significantly boosts self-confidence in performing CS, an effect less noticeable in countries offering hands-on training during residency.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":" ","pages":"1169-1178"},"PeriodicalIF":1.4,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142812517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}